Results for tag: "Prasugrel"

Prasugrel is a medication used to prevent blood clots in people with acute coronary syndrome (ACS) who are undergoing percutaneous coronary intervention (PCI). It is a thienopyridine class antiplatelet drug, and works by inhibiting the binding of adenosine diphosphate (ADP) to its platelet receptor, thus preventing platelet aggregation. Prasugrel is typically used in combination with aspirin and other medications to reduce the risk of heart attack, stroke, and death in people with ACS. Prasugrel is a relatively new drug, having been approved by the U.S. Food and Drug Administration (FDA) in 2009. It is marketed by several pharmaceutical companies, including Daiichi Sankyo, Eli Lilly, and Bristol-Myers Squibb. Prasugrel is available in both tablet and injectable forms. Companies in the Prasugrel market include Daiichi Sankyo, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Pfizer, Sanofi, and Boehringer Ingelheim. Show Less Read more